Javier Cifuentes
Overview
Explore the profile of Javier Cifuentes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
328
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Diaz E, Quezada V, Cifuentes J, Arias Morales N, Reyes L, Munoz-Camargo C, et al.
ACS Omega
. 2024 Nov;
9(45):45402-45420.
PMID: 39554413
Melanoma, known for its aggressive metastatic potential, poses significant treatment challenges. Despite the potent antiproliferative effects of anticancer drugs, systemic toxicity and low water solubility limit their efficacy. This study...
2.
Camargo F, Santamaria-Torres M, Cala M, Guevara-Suarez M, Restrepo Restrepo S, Sanchez-Camargo A, et al.
Metabolites
. 2023 Jul;
13(7).
PMID: 37512495
Over the past decades, Colombia has suffered complex social problems related to illicit crops, including forced displacement, violence, and environmental damage, among other consequences for vulnerable populations. Considerable effort has...
3.
Arango D, Cifuentes J, Puentes P, Beltran T, Bittar A, Ocasion C, et al.
Nanomaterials (Basel)
. 2023 Jun;
13(11).
PMID: 37299685
Gene delivery has emerged as a promising alternative to conventional treatment approaches, allowing for the manipulation of gene expression through gene insertion, deletion, or alteration. However, the susceptibility of gene...
4.
Ravelo-Nieto E, Cifuentes J, Puentes P, Rueda-Gensini L, Quezada V, Ostos C, et al.
Front Bioeng Biotechnol
. 2023 May;
11:1184973.
PMID: 37229494
The limited delivery of cargoes at the cellular level is a significant challenge for therapeutic strategies due to the presence of numerous biological barriers. By immobilizing the Buforin II (BUF-II)...
5.
Cifuentes J, Cifuentes-Almanza S, Puentes P, Quezada V, Gonzalez Barrios A, Calderon-Pelaez M, et al.
Front Bioeng Biotechnol
. 2023 May;
11:1181842.
PMID: 37214285
Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease. Therefore, development of novel technologies and strategies to treat PD is a global health priority. Current treatments...
6.
Munoz L, Jaramillo V, Gantiva-Diaz M, Cifuentes J, Munoz-Camargo C, Cruz J, et al.
Front Bioeng Biotechnol
. 2022 Nov;
10:1003004.
PMID: 36394014
Community acquired infections caused by Meticillin-resistant (MRSA) have become a growing concern due to its impact on the world public health. This microorganism is a commonly spreading pathogen associated predominantly...
7.
Torres-Vanegas J, Cifuentes J, Puentes P, Quezada V, Garcia-Brand A, Cruz J, et al.
Front Chem
. 2022 Oct;
10:974218.
PMID: 36186591
Cell-penetrating agents based on functionalized nanoplatforms have emerged as a promising approach for developing more efficient and multifunctional delivery vehicles for treating various complex diseases that require reaching different intracellular...
8.
Leal A, Cifuentes J, Quezada V, Benincore-Florez E, Cruz J, Reyes L, et al.
Int J Mol Sci
. 2022 Sep;
23(18).
PMID: 36142595
The gangliosidoses GM2 are a group of pathologies mainly affecting the central nervous system due to the impaired GM2 ganglioside degradation inside the lysosome. Under physiological conditions, GM2 ganglioside is...
9.
Leal A, Cifuentes J, Torres C, Suarez D, Quezada V, Gomez S, et al.
Sci Rep
. 2022 Sep;
12(1):15045.
PMID: 36057729
Mucopolysaccharidosis IV A (MPS IVA) is a lysosomal disorder caused by mutations in the GALNS gene. Consequently, the glycosaminoglycans (GAGs) keratan sulfate and chondroitin 6-sulfate accumulate in the lysosomal lumen....
10.
Cifuentes J, Munoz-Camargo C, Cruz J
Nanomaterials (Basel)
. 2022 Aug;
12(16).
PMID: 36014722
The development of novel regenerative technologies based on the implementation of natural extracellular matrix (ECM), or individual components of ECM combined with multifunctional nanomaterials such as graphene oxide and reduced...